Medication
Transformed
The ONE and ONLY
ready-to-use liquid topiramate
The ONLY ready-to-use* liquid zonisamide
The ONE and ONLY alternative formulation to solid oral doses of zonisamide
*Shake well before administering.
Please note that ZONISADE™ (zonisamide oral suspension) 100 mg/5 mL and EPRONTIA® (topiramate) oral solution, 25 mg/mL are two separate pharmaceutical products. ZONISADE™ cannot be used as adjunctive therapy with EPRONTIA® or other forms of topiramate.
EPRONTIA® (topiramate) oral solution, 25 mg/mL
EPRONTIA is indicated for:
- Initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older.
- Adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older.
- Preventive treatment of migraine in patients 12 years of age and older.
Inform patients that a calibrated measuring device is recommended to measure and deliver the prescribed dose accurately. A household teaspoon or tablespoon is not an adequate measuring device.
Please see Important Safety Information throughout and the accompanying full Prescribing Information.
ZONISADE™ (zonisamide oral suspension), 100 mg/5 mL
ZONISADE is indicated as adjunctive therapy for the treatment of partial-onset seizures in adults and pediatric patients 16 years of age and older.
Inform patients that a calibrated measuring device is recommended to measure and deliver the prescribed dose accurately. A household teaspoon or tablespoon is not an adequate measuring device.
Please see Important Safety Information throughout and the accompanying full Prescribing Information.